Melatonin down-regulates hTERT expression induced by either natural estrogens (17β-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

Cancer Letters

Volumn 268, Issue 2, 2008, Pages 272-277

  Martínez Campa, Carlos M ^a   Alonso González, Carolina ^a   Mediavilla, Maria D ^a   Cos, Samuel ^a   González, Alicia ^a   Sanchez Barcelo, Emilio J ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Cadmium; Estradiol; hTERT; MCF 7 cells; Melatonin

Indexed keywords

ANTIESTROGEN; CADMIUM; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MELATONIN; METAL; TELOMERASE REVERSE TRANSCRIPTASE; XENOBIOTIC AGENT;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; CADMIUM; CELL LINE, TUMOR; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MELATONIN; RNA, MESSENGER; TELOMERASE;

EID: 48549093576     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.001     Document Type: Article

References (28)

1. Kirkpatrick K.L., Clark G., Ghilchick M., Newbold R.F., and Mokbel K. hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur. J. Surg. Oncol. 29 (2003) 321-326
2. Bayne S., and Liu J.P. Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol. Cell Endocrinol. 240 (2005) 11-22
3. Moon I.K., and Jarstfer M.B. The human telomere and its relationship to human disease therapy and tissue engineering. Front. Biosci. 12 (2007) 4595-4620
4. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997) 787-791
5. Shpitz B., Zimlichman S., Zemer R., Bomstein Y., Zehavi T., Liverant S., Bernehim J., Kaufman Z., Klein E., Shapira Y., and Klein A. Telomerase activity in ductal carcinoma in situ of the breast. Breast Cancer Res. Treat. 58 (1999) 65-69
6. Mansfield L., Subramanian A., Devalia H., Jiang W., Newbold R.F., and Mokbel K. hTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer a correlative study using RT-PCR. Anticancer Res. 27 (2007) 2265-2268
7. Kyo S., Takakura M., Kanaya T., Zhuo W., Fujimoto K., Nishio Y., Orimo A., and Inoue M. Estrogen activates telomerase. Cancer Res. 59 (1999) 5917-5921
8. Misiti S., Nanni S., Fontemaggi G., Cong Y.S., Wen J., Hirte H.W., Piaggio G., Sacchi A., Pontecorvi A., Bacchetti S., and Farsetti A. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. 20 (2000) 3764-3771
9. Kawagoe J., Ohmichi M., Takahashi T., Ohshima C., Mabuchi S., Takahashi K., Igarashi H., Mori-Abe A., Saitoh M., Du B., Ohta T., Kimura A., Kyo S., Inoue M., and Kurachi H. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J. Biol. Chem. 278 (2003) 43363-43372
10. Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett. 194 (2003) 109-119
11. Sanchez-Barcelo E.J., Cos S., Mediavilla M.D., Martinez-Campa C., Gonzalez A., and Alonso-Gonzalez C. Melatonin-estrogen interactions in breast cancer. J. Pineal Res. 38 (2005) 217-222
12. Garcia-Morales P., Saceda M., Kenney N., Kim N., Salomon D.S., Gottardis M.M., Solomon H.B., Sholler P.F., Jordan V.C., and Martin M.B. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J. Biol. Chem. 269 (1994) 16896-16901
13. Stoica A., Katzenellenbogen B.S., and Martin M.B. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol. Endocrinol. 14 (2000) 545-553
14. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., Clarke R., Lirio P.F.A., Foss A.A., Reiter R., Trock B., Paik S., and Martin M.B. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 9 (2003) 1081-1084
15. Garcia-Pedrero J.M., Del Rio B., Martinez-Campa C., Muramatsu M., Lazo P.S., and Ramos S. Calmodulin is a selective modulator of estrogen receptors. Mol. Endocrinol. 16 (2002) 947-960
16. Glasspool R.M., Burns S., Hoare S.F., Svensson C., and Keith W.N. The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes. Neoplasia 7 (2005) 614-622
17. Bilsland A.E., Stevenson K., Atkinson S., Kolch W., and Keith W.N. Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3. Cancer Res. 66 (2006) 1363-1370
18. Cos S., Fernandez R., Guezmes A., and Sanchez-Barcelo E.J. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58 (1998) 4383-4390
19. Del Rio B., García-Pedrero J.M., Martinez-Campa C., Zuazua P., Lazo P.S., and Ramos S. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J. Biol. Chem. 279 (2004) 38294-38302
20. Leon-Blanco M., Guerrero J.M., Reiter R.J., Calvo J.R., and Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line in vivo and in vitro. J. Pineal Res. 35 (2003) 204-211
21. Leon-Blanco M., Guerrero J.M., Reiter R.J., and Pozo D. RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line. Cancer Lett. 216 (2004) 73-80
22. Martin M.B., Reiter R., Pham T., Avellanet Y.R., Camara J., Lahm M., Pentecost E., Pratap K., Gilmore B.A., Divekar S., Dagata R.S., Bull J.L., and Stoica A. Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144 (2003) 2425-2436
23. Martinez-Campa C., Alonso-Gonzalez C., Mediavilla M.D., Cos S., Gonzalez A., Ramos S., and Sanchez-Barcelo E.J. Melatonin inhibits both ERα activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J. Pineal Res. 40 (2006) 291-296
24. Alonso-Gonzalez C., Gonzalez A., Mazarrasa O., Guezmes A., Sanchez-Mateos S., Martinez-Campa C., Cos S., Sanchez-Barcelo E.J., and Mediavilla M.D. Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary gland and uterus. J. Pineal Res. 42 (2007) 403-410
25. Molis T.M., Spriggs L.L., and Hill S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8 (1994) 1681-1690
26. Rato A.G., Pedrero J.G., Martinez M.A., del Rio B., Lazo P.S., and Ramos S. Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J. 13 (1999) 857-868
27. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
28. Martinez-Campa C., Politis P., Moreau J.L., Kent N., Goodall J., Mellor J., and Goding C.R. Precise nucleosome positioning and the TATA box dictate requirements for the histone H4 tail and the bromodomain factor Bdf1. Mol. Cell. 15 (2004) 69-81